il2 ( human recombinant form ; biogen research co ) was given i.p . at 5000 u thrice daily for 5 consecutive days commencing on day 3 , or for 10 to 11 days commencing on day 10 with some doses omitted at signs of toxicity .
C0021756
il2
C0086418
human